scispace - formally typeset
C

Chris J.L.M. Meijer

Researcher at VU University Amsterdam

Publications -  745
Citations -  83366

Chris J.L.M. Meijer is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Cervical cancer & Cervical intraepithelial neoplasia. The author has an hindex of 128, co-authored 733 publications receiving 78705 citations. Previous affiliations of Chris J.L.M. Meijer include VU University Medical Center & Academic Center for Dentistry Amsterdam.

Papers
More filters
Journal ArticleDOI

High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis.

TL;DR: No support was found for an attribution of hrHPV infection to the development of primary LC, and a clonal relationship between individual tumor pairs was supported by identical hrHPVs genotype, pattern of p16INK4A expression, HPVE7 mRNA expression, and genomic aberrations.
Journal ArticleDOI

Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infections

TL;DR: Positive results were obtained with DNA extracted from clinical samples of genital and cutaneous origin, indicating that HPV infections producing high copy numbers can be detected.
Journal ArticleDOI

The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma.

TL;DR: The findings demonstrate the supplementary value of selective nuclear morphometry to tumor grading and staging, especially in the heterogeneous group of grade 2 carcinomas and the group of superficial tumors (stages Ta and Tl).
Journal ArticleDOI

Histopathological classification of childhood rhabdomyosarcomas: Relationship with clinical parameters and prognosis

TL;DR: This study shows the strong prognostic value of histopathological subtypes and parameningeal tumor localization and confirmed the known impact on prognosis of localization and tumor node metastasis (TNM) stage.
Journal ArticleDOI

HPV-based cervical-cancer screening in China

TL;DR: A multicenter, randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with biweekly cetuximab in the fi rst-line treatment of advanced biliary cancer: interim analysis of the BINGO trial.